Key facts
- Panacea Medical Technologies’s last known valuation is $74.0M (Feb 2025).
- It has raised $15.3M; the latest was PE Growth/Expansion ($5.8M) in Feb 2025.
- Notable investors include New Enterprise Associates, Claypond Capital Partners, IL&FS Investment Managers, MegaDelta Capital Advisors.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Panacea Medical Technologies
- ·The full record, as it builds
Funding rounds
No funding rounds for Panacea Medical Technologies are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Panacea Medical Technologies
Manufacturer of digital radiography and mammography equipment designed to enhance cancer care. The company offers products including multileaf collimators, simulator systems, patient positioning systems, and other medical equipment for radiation therapy and localization of treatment areas, enabling radiotherapy and radiology centers to enhance their treatment techniques.
- Sector
- Healthcare
- HQ
- Kolar, India
- Founded
- 1999
- Employees
- 450
- Website
- panaceamedical.in/
- Ownership
- Privately Held (backing)
Panacea Medical Technologies doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Panacea Medical Technologies shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Panacea Medical Technologies in its N-PORT filings yet. We sweep new filings monthly.